STALEY CAPITAL ADVISERS’s NanoViricides NNVC Stock Holding History

STALEY CAPITAL ADVISERS’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,000	Closed	-$14K	–	177
2019 Q2	$14K	Hold	3,000	–	–	﹤0.01%	179
2019 Q1	$16K	Hold	3,000	–	–	﹤0.01%	170
2018 Q4	$12K	Hold	3,000	–	–	﹤0.01%	168
2018 Q3	$22K	Hold	3,000	–	–	﹤0.01%	169
2018 Q2	$26K	Hold	3,000	–	–	﹤0.01%	169
2018 Q1	$49K	Buy	3,000 +550	+22%	+$10.2K	﹤0.01%	155
2017 Q4	$43K	Sell	2,450 -550	-18%	-$11.2K	﹤0.01%	164
2017 Q3	$68K	Hold	3,000	–	–	0.01%	165
2017 Q2	$81K	Hold	3,000	–	–	0.01%	165
2017 Q1	$67K	Hold	3,000	–	–	0.01%	141
2016 Q4	$64K	Hold	3,000	–	–	0.01%	133
2016 Q3	$101K	Hold	3,000	–	–	0.01%	129
2016 Q2	$96K	Hold	3,000	–	–	0.01%	133
2016 Q1	$131K	Hold	3,000	–	–	0.01%	128
2015 Q4	$71K	Hold	3,000	–	–	0.01%	123
2015 Q3	$71K	Hold	3,000	–	–	0.01%	125
2015 Q2	$104K	Hold	3,000	–	–	0.01%	132
2015 Q1	$135K	Hold	3,000	–	–	0.02%	135
2014 Q4	$163K	Hold	3,000	–	–	0.02%	123
2014 Q3	$180K	Hold	3,000	–	–	0.02%	127
2014 Q2	$254K	Hold	3,000	–	–	0.03%	110
2014 Q1	$192K	Buy	+3,000	New	+$256K	0.02%	126

Other funds holding NNVC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

STALEY CAPITAL ADVISERS's NNVC Position: Q3 2019 in Review

STALEY CAPITAL ADVISERS sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 3,000 shares — an estimated $14K sold.

STALEY CAPITAL ADVISERS first reported a position in NNVC in Q1 2014 and held it in 22 quarters. The position peaked at $254K in Q2 2014. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

STALEY CAPITAL ADVISERS reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
STALEY CAPITAL ADVISERS sold 3,000 NanoViricides shares in Q3 2019, an estimated $14K.
STALEY CAPITAL ADVISERS first reported a position in NanoViricides in Q1 2014 and held it in 22 quarters.
STALEY CAPITAL ADVISERS's NanoViricides position peaked at $254K in Q2 2014.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on STALEY CAPITAL ADVISERS's 13F filing for Q3 2019, filed 8 Nov 2019.